A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Pfizer
Carisma Therapeutics Inc
Celldex Therapeutics
Xencor, Inc.
MacroGenics
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center